EQT Partners

EQT is a differentiated global investment organization with a 26-year history of investing in, and developing and owning, companies and has a demonstrated track-record of attractive, consistent investment performance across multiple geographies, sectors and strategies.[1] Together with a network of industrial advisors, the firm invests in private equity, mid market, infrastructure and credit in Nordic countries, DACH, Greater China and North America.[2]

EQT AB Group
Investment organization
Traded asNasdaq Stockholm: EQT
ISINSE0012853455 
IndustryPrivate Equity
Founded1994 (1994) in Sweden
FounderConni Jonsson
HeadquartersRegeringsgatan 25,
Stockholm
,
Sweden
Key people
Conni Jonsson
(Chairman)
Christian Sinding
(CEO and Managing Partner)
Lennart Blecher
(Deputy Managing Partner)
Caspar Callerström
(COO)
Thomas von Koch
(Deputy Managing Partner)
ProductsInvestments
Private equity funds
Number of employees
650
Websiteeqtgroup.com

History

The company was founded in 1994 by SEB, AEA Investors, and Investor AB, the holding company of the Wallenberg family.[3][4] EQT AB Group is the investment advisor to all the group's funds. It has around 650 employees, of which approximately 330 are within the investment advisory teams. The firm and its affiliates have offices in Amsterdam, Copenhagen, Frankfurt, Helsinki, Hong Kong, London, Luxembourg, Madrid, Munich, Milan, New York, Oslo, Shanghai, Singapore, Stockholm and Zurich. The group has invested more than EUR 62 billion in around 210 companies and exited around 105.[5]

In May 2016, EQT announced the formation of a 566M Euro venture capital arm, called EQT Ventures.[6]

In February 2018, EQT secured 10.8 billion euros ($13.3 billion) for its eighth fund. This amount surpassed the firm's target of 8 billion euros and was greater than its seventh fund, which closed in 2015 with 6.75 billion euros.[7]

Notable investments

In October 2017, EQT acquired medical device company Clinical Innovations from the Pritzker Group for $250 million.[8]

In July 2018, EQT acquired SUSE Linux for 2.5 billion USD. The non-profit arm of the corporation that develops openSUSE will continue to act independently from the stockholders in the corporation.[9]

In May 2019, EQT and affiliates of Digital Colony Partners ("Digital Colony") signed a definitive merger agreement to acquire Zayo Group Holdings, Inc., which provides mission-critical bandwidth to the world's most impactful companies.

In May 2019, consortium led by EQT and ADIA enters exclusive negotiations to acquire skincare company Nestlé Skin Health.

In June 2019, EQT partners acquired Acumatica.[10]

In September 2019, EQT acquired Inexio, a leading provider of fiber-optic internet access in Germany.[11]

References
  1. Espinoza, Javier (7 March 2019). "EQT Co-Founder Leaves to Set Up Socially Responsible Fund". London: Financial Times. Nikkei. Retrieved 12 September 2019.
  2. "Investment by Industry". EQT. 'EQT'. 2015-02-23. Retrieved 2015-02-23.
  3. "SEB Asset Management (Real Estate - Homepage)". IPE Reference Hub. 'IPE Reference Hub'. 2015-02-02. Retrieved 2015-02-23.
  4. Chris V. Nicholson, "EQT Nurtures Companies It Buys, Defying Vulture Label," The New York Times, April 11, 2011.
  5. "Fast facts - EQT". www.eqtgroup.com. Retrieved 2018-05-18.
  6. "Buyout Fund EQT Starts $632 Million Venture Arm Targeting Europe". Bloomberg.com. 2016-05-26. Retrieved 2017-03-03.
  7. Sarah Syed, "EQT Collects $13.3 Billion for Its Largest-Ever Buyout Fund," Bloomberg News, February 22, 2018.
  8. Jonathan D. Rockoff, "Private-Equity Group EQT to Buy Medical Device Company for $250 Million," The Wall Street Journal, October 18, 2017.
  9. "[opensuse-project] SUSE to be acquired by EQT Partners". lists.opensuse.org. Retrieved 2018-07-23.
  10. "IFS and Acumatica to form global cloud ERP powerhouse under EQT ownership". Acumatica Cloud ERP. Retrieved 2019-12-18.
  11. "EQT acquires inexio, a leading provider of fiber-optic internet access in Germany - EQT". www.eqtgroup.com. Retrieved 2020-01-10.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.